Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia
Corresponding Author
Hervé Avet-Loiseau
Laboratory of Hematology, University Hospital, Nantes, France
Unité de Cytogénétique Hématologique, Institut de Biologie, 9 quai Moncousu, 44093 Nantes Cédex, FranceSearch for more papers by this authorRichard Garand
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorFanny Gaillard
Laboratory of Pathology, University Hospital, Nantes, France
Search for more papers by this authorAxelle Daviet
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorMarie-Paule Mellerin
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorNelly Robillard
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorSantosh Arcot
Human Genome Center, Lawrence Livermore National Laboratory, Livermore, California
Search for more papers by this authorMark Batzer
Department of Pathology, Stanley Scott Cancer Center, New Orleans, Louisiana
Search for more papers by this authorPascaline Talmant
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorJean-Luc Harousseau
Department of Clinical Hematology, University Hospital, Nantes, France
Search for more papers by this authorNoël Milpied
Department of Clinical Hematology, University Hospital, Nantes, France
Search for more papers by this authorRégis Bataille
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorCorresponding Author
Hervé Avet-Loiseau
Laboratory of Hematology, University Hospital, Nantes, France
Unité de Cytogénétique Hématologique, Institut de Biologie, 9 quai Moncousu, 44093 Nantes Cédex, FranceSearch for more papers by this authorRichard Garand
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorFanny Gaillard
Laboratory of Pathology, University Hospital, Nantes, France
Search for more papers by this authorAxelle Daviet
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorMarie-Paule Mellerin
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorNelly Robillard
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorSantosh Arcot
Human Genome Center, Lawrence Livermore National Laboratory, Livermore, California
Search for more papers by this authorMark Batzer
Department of Pathology, Stanley Scott Cancer Center, New Orleans, Louisiana
Search for more papers by this authorPascaline Talmant
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorJean-Luc Harousseau
Department of Clinical Hematology, University Hospital, Nantes, France
Search for more papers by this authorNoël Milpied
Department of Clinical Hematology, University Hospital, Nantes, France
Search for more papers by this authorRégis Bataille
Laboratory of Hematology, University Hospital, Nantes, France
Search for more papers by this authorAbstract
The chromosomal translocation t(11;14)(q13;q32) fuses the IGH and CCND1 genes and leads to cyclin D1 overexpression. This genetic abnormality is the hallmark of mantle cell lymphoma (MCL), but is also found in some cases of atypical chronic lymphocytic leukemia (CLL), characterized by a poor outcome. For an unequivocal assessment of this specific chromosomal rearrangement on interphase cells, we developed a set of probes for fluorescence in situ hybridization (FISH). Northern blotting was performed for analysis of the cyclin D1 expression in 18 patients. Thirty-eight patients, with either a typical MCL leukemic phase (17 patients) or atypical CLL with an MCL-type immunophenotype, i.e., CD19+, CD5+, CD23−/low, CD79b/sIgM(D)++, and FMC7+ (21 patients), were analyzed by dual-color interphase FISH. We selected an IGH-specific BAC probe (covering the JH and first constant regions) and a commercially available CCND1 probe. An IGH–CCND1 fusion was detected in 28 of the 38 patients (17 typical MCL and 11 cases with CLL). Cyclin D1 was not overexpressed in two patients with typical MCL and an IGH–CCND1 fusion. In view of the poor prognosis associated with MCL and t(11;14)-positive CLL, we conclude that this set of probes is a valuable and reliable tool for a rapid diagnosis of these entities. Genes Chromosomes Cancer 23:175–182, 1998. © 1998 Wiley-Liss, Inc.
References
- Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnik HR, Sultan C (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukemias: French-American-British (FAB) cooperative group. J Clin Pathol 42: 567–584.
- Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM (1996) Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93: 13931–13936.
- Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
- Coiffier B, Hiddemann W, Stein H (1995) Mantle cell lymphoma: A therapeutic dilemma. Ann Oncol 6: 208–211.
- Coignet LJA, Schuuring E, Kibbelar RE, Raap TK, Kleiverda KK, Bertheas MF, Wiegant J, Beverstock G, Kluin PM (1996) Detection of 1 1q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood 87: 1512–1519.
- Cuneo A, Bigoni R, Negrini M, Bullrich F, Veronese ML, Roberti MG, Bardi A, Rigolin GM, Cavazzini P, Croce CM, Castoldi G (1997) Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation. Cancer Res 57: 1144–1150.
- de Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuuring E, Van Krieken JHJM (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: Rearrangements of the cylin D1 gene. Cancer Res 53: 4148–4152.
- de Boer CJ, van Krieken JHJM, Kluin-Nelemans HC, Kluin PM, Schuuring E (1995a) Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene 10: 1833–1840.
- de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, Van Krieken JHJM (1995b) Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86: 2715–2723.
- Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM (1995) A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including mucosa-asociated lymphoid tissue and monocytoid B cell categories)—A Southwest Oncology Group study. Blood 85: 1075–1082.
- Garand R, Robillard N (1996) Immunophenotypic characterization of acute leukemias and chronic lymphoproliferative disorders: Practical recommendations and classifications. Hematol Cell Ther 38: 471–486.
- Garcia-Conde J, Cabanillas F (1995) Mantle cell lymphoma: A new lymphoproliferative entity with definite histopathological patterns, clinical characteristics and prognostic factors, and an investigational therapeutic approach. Ann Oncol 6: 305–308.
- Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84: 1361–1392.
- Hernandez JM, Mecucci C, Criel A, Meeus P, Michaux L, Van Hoof A, Verhoef G, Louwagie A, Scheiff JM, Michaux JL, Booghaerts M, Vandenberghe H (1995) Cytogenetic analysis of B-cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 9: 2140–2146.
- Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES (1990) Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14: 752–763.
- Leroux D, Le Marc'hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, Caillot P, Jalbert P, Sotto JJ (1991) Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle/intermediate lymphocytic lymphoma? Br J Haematol 77: 346–353.
- Luthra R, Hai S, Pugh WC (1995) Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diag Mol Pathol 4: 4–7.
- Matutes E, Owusu-Ankomah K, Morilla R, Garcia-Marco J, Houlihan A, Que TH, Catovsky D (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8: 1640–1646.
- Monteil M, Callanan M, Dascalescu C, Sotto JJ, Leroux D (1996) Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-colour interphase fluorescence in situ hybridization. Br J Haematol 1996: 656–660.
- Neilson JR, Fegan CD, Milligan DW (1996) Mantle cell leukemia? Br J Haematol 93: 494–495.
- Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, van den Berghe H, de Wolf-Peeters C (1995) Mantle cell lymphoma: A clinicopathologic study of 55 cases. Histopathology 26: 17–24.
- Rimokh R, Berger F, Delsol G, Chanin C, Bertheas MF, French M, Garoscio M, Felman P, Coiffier B, Bryon PA, Rochet M, Gentilhomme O, Germain D, Magaud JP (1993) Rearrangement and overexpression of the bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 81: 3063–3067.
- Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83: 1871–1875.
- Segal GH, Masih AS, Fox AC, Jorgensen T, Scott M, Braylan RC (1995) CD5–expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immuno-phenotype and are associated with an overall poor prognosis. Blood 85: 1570–1579.
- Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO (1995) The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6: 263–266.
- Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwaldt JH, Hagenbeek A, van Glabbeke M, Somers R, Bijnen L, Noordijk EM, De Wolfe-Peeters C (1995) Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hogkin's lymphoma subtypes. J Clin Oncol 13: 1819–1828.
- Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A, Fujita T, Motokura T (1997) Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(1 1;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 89: 965–974.
- Vaandrager JW, Schuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, van Krieken JHJM, Kluin-Nelemans HC, van Ommen GJB, Raap AK, Kluin PM (1996) Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by muticolor DNA fiber fluorescence in situ hybridization. Blood 88: 1177–1182.
- Vandenberghe E, de Wolf-Peeters C, Wlodarska I, Stul M, Louwagie A, Verhoef G, Thomas J, Criel A, Cassiman JJ, Mecucci C, Van den Berghe H (1992) Chromosome 11q rearrangements in B non-Hodgkin's lymphoma. Br J Haematol 81: 212–217.
- Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma: an entity comes of age. Blood 87: 4483–4494.
- Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F (1995) Patterns of survival in mantle cell lymphoma. Ann Oncol 6: 257–262.